Publicacions
-
Ramos JT, De José MI, Dueñas J, Fortuny-Guasch C, González-Montero R, Mellado MJ, Mur A, Navarro M, Otero C, Pocheville I, Muñoz-Fernández MA and Cabrero E.
Safety and antiviral response at 12 months of lopinavir/ritonavir; therapy in human immunodeficiency virus-1-infected children experienced; with three classes of antiretrovirals
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 24(10): 867-873. Nº de cites: 17
-
Ramos JT, de José MI, Polo R, Fortuny-Guasch C, Mellado MJ, Muñoz-Fernández MA, Beceiro J, Bertrán JM, Calvo-Benet C, Chamorro L, Ciria L, Guillén S, González-Montero R, González-Tomé MI, Gurbindo MD, Martín-Fontelos P, Martínez-Pérez J, Moreno D, Munoz-Almagro C, Mur A, Navarro ML, Otero C, Rojo P, Rubio B, Saavedra J, Grupo Colaborativo Español de VIH Pediátrico (CEVIHP), Sociedad Española de Infectologia Pediátrica (SEIP), Asociacion Española de Pediatría (AEP) and Plan Nacional sobre el SIDA del Ministerio de Sanidad y Consumo.
Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 23(5): 279-312. Nº de cites: 5
-
Noguera-Julián A, Fortuny-Guasch C, Munoz-Almagro C, Sanchez E, Vilaseca MA, Artuch-Iriberri R, Pou Fernández J and Jimenez R.
Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals
Pediatrics . 114(5): 598-603. Nº de cites: 74
-
Noguera-Julián A, Fortuny-Guasch C, Pons-Odena M, Cambra-Lasaosa FJ and Palomeque A.
Pneumococcal-associated Purpura fulminans in a healthy infant
PEDIATRIC EMERGENCY CARE . 20(8): 528-530. Nº de cites: 7
-
Cano, JMB, Sanchez-Ramon, S, Ciria, L, Leon, JA, Gurbindo, D, Fortuny-Guasch C, Bertran, JM, Contreras, JR, Ramos, JT, Asensi, O, Mur, A, Resino, R and Munoz-Fernandez, MA.
The effects on infants of potent antiretroviral therapy during pregnancy:: a report from Spain
Medical Science Monitor . 10(5): 179-184. Nº de cites: 22
-
Noguera-Julián A, Pérez-Dueñas B, Fortuny-Guasch C, López-Casas J and Poo P.
Course and treatment of progressive subacute encephalopathy caused by human immunodeficiency virus in children.: The value of botulinum toxin
REVISTA DE NEUROLOGIA . 38(3): 239-243. Nº de cites: 1
-
Vilaseca MA, Artuch-Iriberri R, Sierra-March C, Pineda J, López-Vilches MA, Munoz-Almagro C and Fortuny-Guasch C.
Low serum carnitine in HIV-infected children on antiretroviral treatment
EUROPEAN JOURNAL OF CLINICAL NUTRITION . 57(10): 1317-1322. Nº de cites: 12
-
Noguera-Julián A, Fortuny-Guasch C, Sanchez E, Artuch-Iriberri R, Vilaseca MA, Munoz-Almagro C, Pou Fernández J and Jiménez R.
Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 22(9): 778-782. Nº de cites: 30
-
Ramos F, García-Fructuoso G, Almeda J, Casabona J, Coll O, Fortuny-Guasch C and Grupo ad hoc de infeccion pediátrica por VIH en Cataluña.
Determinantes de la transmisión vertical del VIH en Cataluña (1997-2001): ¿es posible su eliminación?
GACETA SANITARIA . 17(4): 275-282. Nº de cites: 9
-
Noguera-Julián A, Pérez-Dueñas B, Pons-Odena M, Cambra-Lasaosa FJ, Palomeque A, Fortuny-Guasch C, Garcia-Cazorla A and Campistol-Plana J.
Neurofibromatosis type 2 as a result of a de novo mutation:: A case report
REVISTA DE NEUROLOGIA . 35(11): 1030-1033. Nº de cites: 3